Commit To Buy Aerovate Therapeutics At $10, Earn 171.1% Annualized Using Options

Investors considering a purchase of Aerovate Therapeutics Inc (AVTE) stock, but tentative about paying the going market price of $21.39/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $10 strike, which has a bid at the time of this writing of $3.00..